A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer
Clinical trial NCT05635708 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05635708
- Sponsor
- BeiGene
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-07
- Primary completion
- 2025-12-31
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.